Bedside diagnosis of amebiasis could improve patient care. In Bangladesh and Vietnam a novel and simple to use E. histolytica rapid antigen test had 97% sensitivity and 100% specificity when compared to a standard ELISA antigen detection method, and a rapid antibody test had 89-100% sensitivity and 89-95% specificity.
experimental guidelines of the U.S. Department of Health and Human Services, the University of E. histolytica rapid antigen test. The prototype E. histolytica rapid antigen test was supplied by TechLab, Inc. (Blacksburg, VA) and was specifically designed to identify E.
histolytica-specific antigen in stool samples. For this study, 200 µl of stool sample was added to 500 µl of supplied diluent into a 1 mL tube. If the stool sample was formed and unable to be cleanly drawn up into the pipette, approximately a 2 ml equivalent sample was transferred to the tube using a wooden applicator. The samples were mixed by lightly vortexing. They were then centrifuged at 1500 x g for 2 minutes and 500 µl of supernatant was resuspended in a new tube.
Two drops of conjugate (60 µl), consisting of 7F4 antibody coupled to horseradish peroxidase (HRP) in a buffered solution, were added to the sample and the tube was again vortexed. The sample/conjugate mixture incubated at room temperature for 15 minutes. A total of 400 µl of the sample was then added to a membrane through a sample well and allowed to migrate over two antibody-striped lines: a control line and a test line. The control line bound the conjugate regardless of sample antigen content and indicated whether the test ran properly. The test line contained antibodies specific for E. histolytica lectin and trapped antigen-conjugate complexes if present in the sample. The sample was allowed to incubate at room temperature for 10 minutes. 
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on June 21, 2017 by guest http://jcm.asm.org/ Downloaded from E. histolytica rapid antibody test. The prototype E. histolytica rapid antibody test was supplied by TechLab, Inc. (Blacksburg, VA) and was designed as a modified version of the protocol for the antigen test (see above) but using a reaction well "flow-thru" format. The 25 µl of serum sample was diluted with 225 µl of supplied buffer and 250 µl of diluted sample applied to the reaction well and allowed to completely absorb for 1 minute. The reaction well was washed with 2 drops of membrane wash buffer, followed by a second wash after complete absorption. The membrane it flowed through had two dots. The control dot was designed to bind any anti-human IgG, while the test dot consisted of an E. histolytica-specific recombinant protein, termed LecA, to capture E. histolytica-specific IgG. Anti-human IgG conjugated to HRP was added to the reaction well and allowed to react for 1 minute. The well was again washed twice using 2 drops of membrane wash solution. To determine presence of bound human IgG, 2 drops of substrate solution was added, and the HRP enzyme converted the substrate to a blue color if it was present on the control dot or the test dot. The test was allowed to develop for 5 minutes and 2 drops of a stop solution was added before the test was read.
E. histolytica antibody ELISA. The anti-lectin immunoglobulin G (IgG) ELISA procedure performed in Dhaka consisted of a highly purified, native E. histolytica lectin isolated using monoclonal antibody chromatography as a detection antigen (13) . For the work in Vietnam the antibody ELISA used a recombinant fragment of the E. histolytica Gal/GalNAc-specific adherence lectin, a recombinant 125-kDa E. histolytica surface protein or an IFA with whole E. histolytica trophozoites (23).
The E. histolytica Rapid Antigen Test had a sensitivity of 97% and specificity of 100% when compared to E. histolytica II ELISA test (Table 1A , 1B). 77% of the stool samples were from asymptomatic patients. The E. histolytica rapid antibody test of 337 serum samples from Bangladesh had a sensitivity of 100% and specificity of 95% when compared to the E. histolytica adherence lectin antibody ELISA (Table 2A, 
2B). When the E. histolytica rapid antibody test
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on June 21, 2017 by guest http://jcm.asm.org/ Downloaded from was evaluated using 150 serum samples from Hue, Vietnam, the sensitivity was 89% and specificity was 92% (Table 3A , 3B) (24). The differences between the two sites is most likely due to differences in the serology tests that were used for comparison. In Bangladesh the same antigen as present in the rapid test was used, whereas we in Hamburg independent antigens were used. Accordingly, the results from Bangladesh were more concordant.
The major conclusion of this study is that the prototype E. histolytica rapid antigen individual-use test and the prototype E. histolytica rapid antibody individual-use test can be reliably used for routine diagnosis of intestinal and extra-intestinal Entamoeba histolytica infection. It should be noted however that a negative antigen test does not rule out an amebiasis, as antigen detection is approximately 80% sensitive compared to real-time PCR. Both rapid tests can be run at the bedside for individual patients, they do not require high-tech equipment to process, and analysis of the results can be accomplished by healthcare workers with very little training. 
